|
|
CHARACTERIZATION OF ALPHA1-ADRENOCEPTOR SUBTYPES IN
HUMAN RADIAL, INTERNAL MAMMARY ARTERIES AND SAPHENOUS VEIN M
Yan* and Y L Lim. National Heart
Centre of Singapore and Department of Cardiology, Box Hill Hospital, Vic. Spasm of the coronary bypass grafts using the radial artery (RA),
internal mammary artery (IMA) and saphenous vein (SV) occurs in
clinic. It appears that Alpha1-adrenoceptor (AR) is the
main mediator of spasm in the human RA, IMA and SV. We aimed
to study the distribution of Alpha1-AR subtypes in these
vessels since this information may have clinical significance in
designing potential therapeutic targets for preventing spasm of
coronary grafts. The segments of blood vessels were obtained from 8 patients undergoing
the bypass surgery. These patients were selected because they were
not receiving any Alpha-AR agonists or antagonists. We examined
the Alpha1-AR subtypes in RA, IMA and SV using reverse
transcription polymerase chain reaction (RT-PCR), DNA-DNA hybridization
analysis and functional affinities experiments. Using Alpha1A-,
Alpha 1B- or Alpha1D-AR subtypes oligonucleotide
primers sets to amplify human RA, IMA and SV cDNAs, DNA-DNA Hybridization
was used to analyze PCR products. Cumulative concentration-response
curves were constructed for noradrenaline Alpha-AR agonist)-induced
contraction, and the effects of competitive antagonists were examined
versus the potency in RA, IMA and SV. The results are as follows: (1) The PCR products for Alpha1A-AR
in RA and SV and Alpha1B-AR in IMA were observed, but
Alpha1D-AR was not detectable in RA, IMA and SV. DNA-DNA
hybridization confirmed the presence of Alpha1A-, Alpha1B-
and Alpha1D-AR in RA, IMA and SV. (2) Prazosin, the a1-AR
antagonist, phentolamine, a1- and a2-AR antagonist,
5-MU and WB4101, a1A-AR antagonists, were competitively antagonized the
noradrenaline-induced contraction. The selective Alpha1D-AR
antagonist BMY 7378 had a low affinity in RA, IMA and SV. Chloroethylclonidine,
a a1B and a1D-AR antagonist, inhibited the
noradrenaline-induced contraction in IMA and SV, but no effect in
RA. Functional and binding affinities in RA, IMA and SV correlated
well (Alpha1A r = 0.96 in RA; Alpha1B r =
0.91 in IMA; Alpha1A r = 0.89 and Alpha1B
r = 0.98 in SV). The results suggest that the Alpha1A-AR in RA, Alpha1B-AR
in IMA and Alpha1A-and Alpha1B-ARs in SV is
the main functional and expressed receptor subtypes. These
data emphases the need for prevention of catecholamine induced vasospasm,
reinforcing consideration of Alpha1A antagonists to RA,
Alpha1B antagonists to IMA, and Alpha1A and
Alpha1B antagonists to SV, respectively, during and after
coronary artery bypass surgery. |
|